XORTX Therapeutics (NASDAQ:XRTX – Get Free Report) issued its quarterly earnings results on Saturday. The technology company reported ($1.05) earnings per share (EPS) for the quarter, FiscalAI reports.
XORTX Therapeutics Stock Down 0.9%
XORTX Therapeutics stock opened at $2.17 on Friday. The stock has a market cap of $3.95 million, a P/E ratio of -0.83 and a beta of 0.73. XORTX Therapeutics has a twelve month low of $1.73 and a twelve month high of $7.05. The company’s 50-day moving average price is $2.11 and its two-hundred day moving average price is $2.23.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of XORTX Therapeutics in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, XORTX Therapeutics currently has an average rating of “Sell”.
Institutional Investors Weigh In On XORTX Therapeutics
An institutional investor recently raised its position in XORTX Therapeutics stock. Citadel Advisors LLC raised its stake in shares of XORTX Therapeutics Inc. (NASDAQ:XRTX – Free Report) by 124.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 86,326 shares of the technology company’s stock after purchasing an additional 47,858 shares during the quarter. Citadel Advisors LLC owned 1.24% of XORTX Therapeutics worth $70,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 0.23% of the stock is owned by hedge funds and other institutional investors.
About XORTX Therapeutics
Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.
Further Reading
- Five stocks we like better than XORTX Therapeutics
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
